Mawer Investment Management Ltd. Sells 2,396 Shares of Danaher Co. (NYSE:DHR)

Mawer Investment Management Ltd. lowered its stake in shares of Danaher Co. (NYSE:DHR) by 0.5% during the third quarter, Holdings Channel.com reports. The firm owned 445,300 shares of the conglomerate’s stock after selling 2,396 shares during the quarter. Mawer Investment Management Ltd.’s holdings in Danaher were worth $123,802,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Rockport Wealth LLC acquired a new stake in Danaher in the first quarter valued at approximately $516,000. O Shaughnessy Asset Management LLC raised its holdings in Danaher by 26.0% during the first quarter. O Shaughnessy Asset Management LLC now owns 43,730 shares of the conglomerate’s stock worth $10,920,000 after purchasing an additional 9,031 shares during the last quarter. PYA Waltman Capital LLC boosted its holdings in Danaher by 10.0% in the first quarter. PYA Waltman Capital LLC now owns 32,429 shares of the conglomerate’s stock valued at $8,098,000 after acquiring an additional 2,935 shares during the last quarter. Lake Street Advisors Group LLC increased its holdings in Danaher by 50.3% in the first quarter. Lake Street Advisors Group LLC now owns 6,211 shares of the conglomerate’s stock valued at $1,553,000 after buying an additional 2,079 shares during the last quarter. Finally, Puzo Michael J grew its holdings in Danaher by 9.0% in the 1st quarter. Puzo Michael J now owns 45,993 shares of the conglomerate’s stock worth $11,485,000 after buying an additional 3,788 shares in the last quarter. 79.05% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling at Danaher

In other Danaher news, SVP Georgeann Couchara sold 952 shares of the business’s stock in a transaction dated Monday, August 26th. The shares were sold at an average price of $268.37, for a total value of $255,488.24. Following the transaction, the senior vice president now owns 4,212 shares in the company, valued at approximately $1,130,374.44. The trade was a 18.44 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Company insiders own 11.10% of the company’s stock.

Danaher Stock Down 0.4 %

DHR stock traded down $1.03 during trading hours on Monday, reaching $229.47. 110,332 shares of the stock were exchanged, compared to its average volume of 2,748,222. The company has a market cap of $165.74 billion, a price-to-earnings ratio of 43.99, a PEG ratio of 4.24 and a beta of 0.85. The firm’s 50-day moving average is $262.20 and its 200-day moving average is $260.57. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.37 and a quick ratio of 1.01. Danaher Co. has a 12 month low of $207.63 and a 12 month high of $281.70.

Danaher (NYSE:DHR) last announced its quarterly earnings data on Tuesday, October 22nd. The conglomerate reported $1.71 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.57 by $0.14. The business had revenue of $5.80 billion for the quarter, compared to analysts’ expectations of $5.59 billion. Danaher had a net margin of 16.39% and a return on equity of 10.62%. The firm’s quarterly revenue was up 3.1% compared to the same quarter last year. During the same period last year, the firm posted $2.02 earnings per share. On average, equities research analysts expect that Danaher Co. will post 7.51 earnings per share for the current year.

Danaher Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, October 25th. Investors of record on Friday, September 27th were issued a $0.27 dividend. The ex-dividend date was Friday, September 27th. This represents a $1.08 dividend on an annualized basis and a dividend yield of 0.47%. Danaher’s dividend payout ratio is presently 20.61%.

Analyst Upgrades and Downgrades

DHR has been the subject of several research reports. Evercore ISI increased their target price on shares of Danaher from $275.00 to $278.00 and gave the company an “outperform” rating in a research note on Tuesday, October 1st. Barclays cut their price objective on shares of Danaher from $285.00 to $275.00 and set an “equal weight” rating on the stock in a research report on Wednesday, October 23rd. UBS Group decreased their price target on shares of Danaher from $309.00 to $305.00 and set a “buy” rating on the stock in a research note on Wednesday, October 23rd. Royal Bank of Canada lowered their price objective on shares of Danaher from $333.00 to $311.00 and set an “outperform” rating for the company in a research report on Wednesday, October 23rd. Finally, TD Cowen boosted their price target on shares of Danaher from $310.00 to $315.00 and gave the stock a “buy” rating in a research note on Wednesday, October 23rd. Five investment analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $287.16.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.